We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > hormone receptor

News List

Daiichi Sankyo Initiates Pivotal Phase 3 Trial of [Fam-] DS-8201 americanpharmaceuticalreview
January 15, 2019
Daiichi Sankyo announced that the first patient has been dosed in DESTINY-Breast04, a global pivotal phase 3 study evaluating the safety and efficacy of [fam-] trastuzumab deruxtecan (DS-8201)....
FDA approves first cancer drug through new oncology review pilot that enables greater development efficiency worldpharmanews
July 19, 2018
The U.S. Food and Drug Administration today approved Kisqali (ribociclib) in combination with an aromatase inhibitor for the treatment of pre/perimenopausal or postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor recepto